Review



rabbit polyclonal  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech rabbit polyclonal
    Rabbit Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1324 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/c-Myc+Antibody/bio_rxiv__64898__2026__11__03__764021-128-45-48
    Average 96 stars, based on 1324 article reviews
    rabbit polyclonal - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: Deubiquitinase UCH-L1 confers paclitaxel resistance via stabilizing PKM2 to promote glycolysis in triple-negative breast cancer.
    Article Snippet: Reagents and antibodies Paclitaxel (S1150), the proteasome inhibitor MG132 (S2619) and protein synthesis inhibitor cycloheximide (CHX, S7418) were purchased from Selleck (Shanghai, China). .. Antibodies used in immunoblotting: UCH-L1 (66230-1-Ig, 1:1000), PKM2 (60268-1-Ig, 1:1000), β-actin (66009-1-Ig, 1:5000), Myc (60003-2- Ig, 1:5000), HA (66006-2-Ig, 1:5000), Flag (66008-4-lg, 1:5000), GST (10000- 0-AP, 1:4000) were purchased from Proteintech. .. Antibodies against UCH-L1 (13179, 1:200 for immunofluorescence and IHC staining) was purchased from Cell Signaling Technology.

    Article Title: HSPA5 promotes YAP/TAZ stability independently of the Hippo pathway and induces proneural-to-mesenchymal transition in glioblastoma
    Article Snippet: After washing, membranes were incubated with HRP-conjugated secondary antibodies at room temperature for 2 h. Protein bands were visualized using Super chemiluminescence (ECL) reagents (#S6009L, UElandy, China) and detected using the Chemiluminescent Imaging System (Tanon, China). .. The primary antibodies used for western blot analysis were as follows: HSPA5 (1:1000, Cat No. 66574-1-Ig, Proteintech, China), HSPA5 (1:1000, Cat No. 11587-1-AP, Proteintech, China), YAP (1:1000, Cat No. 13584-1-AP, Proteintech, China), TAZ (1:1000, Cat No. 23306-1-AP, Proteintech, China), p-YAP (S127) (1:1000, Cat No. 4911, Cell Signaling Technology, USA), p-TAZ (S89) (1:1000, Cat No. 59971, Cell Signaling Technology, USA), β-TrCP (1:1000, Cat No. 28393-1-AP, Proteintech, China), c-MET (1:1000, Cat No. 25869-1-AP, Proteintech, China), CD44 (1:1000, Cat No. 15675-1-AP, Proteintech, China), SOX2 (1:1000, Cat No. 11064-1-AP, Proteintech, China), OLIG2 (1:1000, Cat No. 13999-1-AP, Proteintech, China), Ub (1:2000, Cat No. A19686, Abclonal, China), GAPDH (1:5000, Cat No. 60004-1-Ig, Proteintech, China), GAPDH (1:5000, Cat No. 10494-1-AP, Proteintech, China), H3 (1:2000, Cat No. 17168-1-AP, Proteintech, China), GST (1:1000, Cat No. 10000-0-AP, Proteintech, China), Flag (1:1000, Cat No. 20543-1-AP, Proteintech, China), His (1:1000, Cat No. 66005-1-Ig, Proteintech, China), Myc (1:1000, Cat No. 60003-2-Ig, Proteintech, China). .. Nuclear and cytoplasmic proteins were extracted using the Nuclear and Cytoplasmic Protein Extraction Kit (#P0027, Beyotime, China) according to the manufacturer’s instructions.

    Article Title: PRKD1/EIF5A/β-catenin axis inhibits tumorigenesis and metastasis in non-small-cell lung cancer.
    Article Snippet: Western blot showed expression of PRKD1 and EIF5A. (F) A549 and H1299 cells were transfected with siRNA targeting PRKD1. qRT-PCR showed the mRNA levels of PRKD1 and EIF5A. (G) A549 cells were transfected with the PRKD1 plasmid and treated with PRKD1 inhibitor CID-2,011,756, followed by immunoblotting. (H) A549 cells were transfected with the PRKD1 plasmid and treated with proteasome inhibitor MG132, followed by immunoblotting. (I) A549 cells were transfected with the PRKD1 plasmid and then treated with CHX for the indicated time periods before being harvested for immunoblotting. (J) The band density of EIF5A in (I) was quantified using ImageJ software, normalized to β-actin first, then normalized to the t = 0 time point. (K) HEK293FT cells were transfected with the indicated constructs. .. Cells were treated with MG132 (20 mM for 4 h) before lysis and then subjected to anti-MYC IP followed by immunoblot analysis 1 3 Page 11 of 18 134 Clinical and Experimental Medicine (2026) 26:134 1 3 134 Page 12 of 18 Clinical and Experimental Medicine (2026) 26:134 1:1000), EIF5A (CY5637, abways, 1:1000), Ki67 (CY5542, abways, 1:200), FLAG (20543-1-AP, proteintech, 1:10000), HA (51064-2-AP, proteintech, 1:10000), MYC (10828-1- AP, proteintech, 1:10000), HIS (66005-1-Ig, proteintech, 1:10000), β-actin (AF5003, Beyotime, 1:20000), Lamin A/C (2032, Cell Signaling Technology, 1:10000), GAPDH (60004-1-Ig, proteintech, 1:20000). ..

    Article Title: KIAA1429 promotes clear cell renal cell carcinoma progression by regulating MYC mRNA stability
    Article Snippet: .. The primary antibodies used in western blotting were as follows: KIAA1429 (1:1000, Proteintech), β-actin (1:5000, Proteintech), Vimentin (1:1000, Proteintech), N-cadherin (1:1000, Proteintech), E-cadherin (1:1000, Proteintech) and MYC (1:1000, Proteintech). .. The secondary antibody used in western blotting was HRP Goat Anti-Rabbit IgG (1:5000, Proteintech) and HRP Goat Anti-Mouse IgG (1:5000, Proteintech).The original WB image can be found in .

    Ubiquitin Proteomics:

    Article Title: Fundus albipunctatus disease-associated RDH5/L310delinsEV mutation undertakes AMFR-mediated polyubiquitination and degradation in proteasome.
    Article Snippet: Genetic mutations in retinol dehydrogenase 5 (RDH5) are associated with the inherited autosomal recessive retinal degeneration diseases, especially fundus albipunctatus (FA).. Most of RDH5 mutants exhibit downregulation of RDH5 protein expression.. However, the regulatory mechanism remains unclear.

    Lysis:

    Article Title: PRKD1/EIF5A/β-catenin axis inhibits tumorigenesis and metastasis in non-small-cell lung cancer.
    Article Snippet: Western blot showed expression of PRKD1 and EIF5A. (F) A549 and H1299 cells were transfected with siRNA targeting PRKD1. qRT-PCR showed the mRNA levels of PRKD1 and EIF5A. (G) A549 cells were transfected with the PRKD1 plasmid and treated with PRKD1 inhibitor CID-2,011,756, followed by immunoblotting. (H) A549 cells were transfected with the PRKD1 plasmid and treated with proteasome inhibitor MG132, followed by immunoblotting. (I) A549 cells were transfected with the PRKD1 plasmid and then treated with CHX for the indicated time periods before being harvested for immunoblotting. (J) The band density of EIF5A in (I) was quantified using ImageJ software, normalized to β-actin first, then normalized to the t = 0 time point. (K) HEK293FT cells were transfected with the indicated constructs. .. Cells were treated with MG132 (20 mM for 4 h) before lysis and then subjected to anti-MYC IP followed by immunoblot analysis 1 3 Page 11 of 18 134 Clinical and Experimental Medicine (2026) 26:134 1 3 134 Page 12 of 18 Clinical and Experimental Medicine (2026) 26:134 1:1000), EIF5A (CY5637, abways, 1:1000), Ki67 (CY5542, abways, 1:200), FLAG (20543-1-AP, proteintech, 1:10000), HA (51064-2-AP, proteintech, 1:10000), MYC (10828-1- AP, proteintech, 1:10000), HIS (66005-1-Ig, proteintech, 1:10000), β-actin (AF5003, Beyotime, 1:20000), Lamin A/C (2032, Cell Signaling Technology, 1:10000), GAPDH (60004-1-Ig, proteintech, 1:20000). ..

    Recombinant:

    Article Title: African swine fever virus protein R298L opposes the NF-κB signaling pathway and interferon-mediated pathway.
    Article Snippet: African swine fever virus (ASFV) is a large DNA virus that is highly pathogenic to domestic pigs and severely threatens the global pig industry.. ASFV has evolved a range of strategies to evade or suppress the innate antiviral immunity of the host in order to promote its own infection and proliferation.. However, the molecular mechanisms underlying the inhibition of innate antiviral immunity by ASFV-encoded proteins remain unclear.

    Reporter Assay:

    Article Title: African swine fever virus protein R298L opposes the NF-κB signaling pathway and interferon-mediated pathway.
    Article Snippet: African swine fever virus (ASFV) is a large DNA virus that is highly pathogenic to domestic pigs and severely threatens the global pig industry.. ASFV has evolved a range of strategies to evade or suppress the innate antiviral immunity of the host in order to promote its own infection and proliferation.. However, the molecular mechanisms underlying the inhibition of innate antiviral immunity by ASFV-encoded proteins remain unclear.

    Bioprocessing:

    Article Title: African swine fever virus protein R298L opposes the NF-κB signaling pathway and interferon-mediated pathway.
    Article Snippet: African swine fever virus (ASFV) is a large DNA virus that is highly pathogenic to domestic pigs and severely threatens the global pig industry.. ASFV has evolved a range of strategies to evade or suppress the innate antiviral immunity of the host in order to promote its own infection and proliferation.. However, the molecular mechanisms underlying the inhibition of innate antiviral immunity by ASFV-encoded proteins remain unclear.

    Hemagglutination Assay:

    Article Title: African swine fever virus protein R298L opposes the NF-κB signaling pathway and interferon-mediated pathway.
    Article Snippet: African swine fever virus (ASFV) is a large DNA virus that is highly pathogenic to domestic pigs and severely threatens the global pig industry.. ASFV has evolved a range of strategies to evade or suppress the innate antiviral immunity of the host in order to promote its own infection and proliferation.. However, the molecular mechanisms underlying the inhibition of innate antiviral immunity by ASFV-encoded proteins remain unclear.

    Cell-Signaling:

    Article Title: African swine fever virus protein R298L opposes the NF-κB signaling pathway and interferon-mediated pathway.
    Article Snippet: African swine fever virus (ASFV) is a large DNA virus that is highly pathogenic to domestic pigs and severely threatens the global pig industry.. ASFV has evolved a range of strategies to evade or suppress the innate antiviral immunity of the host in order to promote its own infection and proliferation.. However, the molecular mechanisms underlying the inhibition of innate antiviral immunity by ASFV-encoded proteins remain unclear.

    other:

    Article Title: CD59 promotes pancreatic cancer progression via a tumor cell-intrinsic JAK2-STAT3 signaling axis.
    Article Snippet: Pancreatic cancer is a highly aggressive malignancy with limited therapeutic options.. Although the complement system has been implicated in tumor biology, its tumor cell–intrinsic roles in pancreatic cancer remain unclear.. Here, we identify the complement regulatory protein CD59 as a critical driver of pancreatic cancer progression through a cell-intrinsic signaling mechanism.



    Similar Products

    cells  (ATCC)
    95
    ATCC cells
    Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/MYC+1-9E10%2E2/bio_rxiv__64898__2026__10__30__763229-223-6-9
    Average 95 stars, based on 1 article reviews
    cells - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    97
    MedChemExpress myc
    Myc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/Anti-c-Myc+Magnetic+Beads/pm42980348-56-3-12
    Average 97 stars, based on 1 article reviews
    myc - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti myc tag
    Anti Myc Tag, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/Myc-Tag+Mouse+mAb/pmc13752516-39-12-15
    Average 97 stars, based on 1 article reviews
    anti myc tag - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc myc tag proteins
    Myc Tag Proteins, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/Myc-Tag+Rabbit+mAb/pmc13749613-76-32-35
    Average 96 stars, based on 1 article reviews
    myc tag proteins - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit polyclonal
    Rabbit Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/c-Myc+Antibody/bio_rxiv__64898__2026__11__03__764021-128-45-48
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    OriGene anti myc for ib or ip
    G2-state Cdc25C differs from original-state Cdc25C in basal activity and phosphoactivation (A) Schematic diagram of Xenopus Cdc25C interactions with binding partners. (B) Myc-Cdc25C immunoprecipitated from its TNT product (IP-Cdc25C) was mock-treated with EB or incubated with IOE or MEE for 1 h. The washed immunocomplexes were analyzed for Cdc25C mobility shifts by <t>anti-Myc</t> immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of partially purified phospho-Cdk1 (pCdk1) for the indicated times (right). In parallel, TNT-produced myc-Cdc25C 62DE was immunoprecipitated and analyzed. (C) IP-Cdc25C S287A was analyzed as described for IP-Cdc25C in (B). (D) IP-Cdc25C was mock-treated with EB or incubated with p9-Cdk1 or MEE for 1 h. Washed immunocomplexes were examined for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of endogenous Cdk1 in 1:10-diluted IOE⁎ supplemented with okadaic acid (IOE⁎/OA) for the indicated times (right). Similar results were obtained in four additional independent experiments with moderate variations in phosphorylation conditions. (E) IOE-Cdc25C (lower images) was mock-treated with EB or incubated with p9-Cdk1 or MEE for 1 h and analyzed as in (D). The results shown are representative of five independent experiments.
    Anti Myc For Ib Or Ip, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/9E10%2C+Anti-Myc+Monoclonal+Antibody/pmc13769019-5-0-6
    Average 95 stars, based on 1 article reviews
    anti myc for ib or ip - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    90
    OriGene c terminal myc flag tag
    Overexpression of Trx1 mitigates TDP-43 pathology in N2a cells. (A,B) Overexpressing Trx1 significantly reduces cytoplasmic TDP-43 aggregation in N2a cells. 48 h post-transfection as indicated, N2a cells were stained with anti -TDP-43 (A). Yellow arrows indicate cytoplasmic TDP-43 inclusions. Cytoplasmic TDP-43 inclusions were normalized to the corresponding cell number and presented as a percentage of cells with cytoplasmic TDP-43 inclusions (B) (n = 3, one-way ANOVA, post-hoc Tukey's test). (C-F) Overexpressing Trx1 significantly reduces cleaved caspase 3 in N2a cells. 48 h post-transfection, c-Cas3 was assessed by immunostaining with c-Cas3-specific antibody (C) and Western blot analysis with pro-caspase-3 antibody (E). The percentages of c-Cas3-positive cells were quantified from immunostaining images (D), and c-Cas3 protein levels were quantified by Western blotting and normalized to the GAPDH level and presented relative to the mean value of the control group (F). (D: n = 4, one-way ANOVA, post-hoc Tukey's test, F: n = 3, unpaired t- test). Nuclei were stained with DAPI (blue). All scale bars correspond to 25 μm. All values are means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
    C Terminal Myc Flag Tag, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/TXN+(NM_003329)+Human+Tagged+ORF+Clone/pmc13769236-58-16-23
    Average 90 stars, based on 1 article reviews
    c terminal myc flag tag - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    93
    Addgene inc addgene rat myc tagged wnk1
    Overexpression of Trx1 mitigates TDP-43 pathology in N2a cells. (A,B) Overexpressing Trx1 significantly reduces cytoplasmic TDP-43 aggregation in N2a cells. 48 h post-transfection as indicated, N2a cells were stained with anti -TDP-43 (A). Yellow arrows indicate cytoplasmic TDP-43 inclusions. Cytoplasmic TDP-43 inclusions were normalized to the corresponding cell number and presented as a percentage of cells with cytoplasmic TDP-43 inclusions (B) (n = 3, one-way ANOVA, post-hoc Tukey's test). (C-F) Overexpressing Trx1 significantly reduces cleaved caspase 3 in N2a cells. 48 h post-transfection, c-Cas3 was assessed by immunostaining with c-Cas3-specific antibody (C) and Western blot analysis with pro-caspase-3 antibody (E). The percentages of c-Cas3-positive cells were quantified from immunostaining images (D), and c-Cas3 protein levels were quantified by Western blotting and normalized to the GAPDH level and presented relative to the mean value of the control group (F). (D: n = 4, one-way ANOVA, post-hoc Tukey's test, F: n = 3, unpaired t- test). Nuclei were stained with DAPI (blue). All scale bars correspond to 25 μm. All values are means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
    Addgene Rat Myc Tagged Wnk1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/pCMV-myc-Wnk1+(Plasmid+%2338779)/pm42982891-59-11-11
    Average 93 stars, based on 1 article reviews
    addgene rat myc tagged wnk1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Sino Biological pcmv3 pecam 1 myc
    Overexpression of Trx1 mitigates TDP-43 pathology in N2a cells. (A,B) Overexpressing Trx1 significantly reduces cytoplasmic TDP-43 aggregation in N2a cells. 48 h post-transfection as indicated, N2a cells were stained with anti -TDP-43 (A). Yellow arrows indicate cytoplasmic TDP-43 inclusions. Cytoplasmic TDP-43 inclusions were normalized to the corresponding cell number and presented as a percentage of cells with cytoplasmic TDP-43 inclusions (B) (n = 3, one-way ANOVA, post-hoc Tukey's test). (C-F) Overexpressing Trx1 significantly reduces cleaved caspase 3 in N2a cells. 48 h post-transfection, c-Cas3 was assessed by immunostaining with c-Cas3-specific antibody (C) and Western blot analysis with pro-caspase-3 antibody (E). The percentages of c-Cas3-positive cells were quantified from immunostaining images (D), and c-Cas3 protein levels were quantified by Western blotting and normalized to the GAPDH level and presented relative to the mean value of the control group (F). (D: n = 4, one-way ANOVA, post-hoc Tukey's test, F: n = 3, unpaired t- test). Nuclei were stained with DAPI (blue). All scale bars correspond to 25 μm. All values are means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
    Pcmv3 Pecam 1 Myc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/Human+CD31%2FPECAM-1+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-Myc+tag/10__1038_slash_s41467___026___79134___z-410-20-16
    Average 94 stars, based on 1 article reviews
    pcmv3 pecam 1 myc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology sirnas targeting c myc
    a, RADAR mechanism. RADAR consists of three parts: an optional marker (red), a sensor sequence (orange) complementary to the target RNA except an A:C mismatch at the UAG stop codon, and a cargo (green). In the absence of target RNA, the cargo is not expressed due to the stop codon in the sensor. When sensor is bound to its target, the double-strand RNA formed between sensor and target will induce ADAR-mediated A-to-I editing, thus removing the stop codon and enabling cargo expression. b, ORCA overview. c, RT-qPCR C q values of four gene targets in four cell lines. Each dot represents one technical replicate. d , Schematic showing targeting regions of identified sensors for each transcript. Colored box: coding sequence. Black line: 5’ or 3’ UTR. Red line: sensor target. Drawn to scale (MYC-s1 = 180 nt). e,f , GFP intensity of indicated cells transfected with the RADAR reporter (top) plus ADAR1p150 plasmids. Scramble sensor: a control for background payload expression. g-i , Representative fluorescent images of cells transfected with RADAR (shown in e and f ) and ADAR1p150 plasmids. SNU16 and HuG1N are suspension cells. Images taken at one Z-section. Scale bar = 275 μm. j-l , GFP intensity of COLO320DM ( j ), SNU16 ( k ), and HuG1N ( l ) cells co-transfected with RADAR (shown in e and f ), ADAR1p150 plasmids and <t>siRNA.</t> <t>Ctrl:</t> <t>non-targeting</t> siRNA. Each dot represents one biological replicate in e , f , j , k , l . Error bar represents standard deviation in all figures. Significance determined by two-tailed Student’s t -test. *: p<0.05, **: p<0.01, ***: p<0.001, ****: p<0.0001.
    Sirnas Targeting C Myc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myc/c-Myc+siRNA/bio_rxiv__64898__2026__11__02__763782-179-0-18
    Average 93 stars, based on 1 article reviews
    sirnas targeting c myc - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    G2-state Cdc25C differs from original-state Cdc25C in basal activity and phosphoactivation (A) Schematic diagram of Xenopus Cdc25C interactions with binding partners. (B) Myc-Cdc25C immunoprecipitated from its TNT product (IP-Cdc25C) was mock-treated with EB or incubated with IOE or MEE for 1 h. The washed immunocomplexes were analyzed for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of partially purified phospho-Cdk1 (pCdk1) for the indicated times (right). In parallel, TNT-produced myc-Cdc25C 62DE was immunoprecipitated and analyzed. (C) IP-Cdc25C S287A was analyzed as described for IP-Cdc25C in (B). (D) IP-Cdc25C was mock-treated with EB or incubated with p9-Cdk1 or MEE for 1 h. Washed immunocomplexes were examined for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of endogenous Cdk1 in 1:10-diluted IOE⁎ supplemented with okadaic acid (IOE⁎/OA) for the indicated times (right). Similar results were obtained in four additional independent experiments with moderate variations in phosphorylation conditions. (E) IOE-Cdc25C (lower images) was mock-treated with EB or incubated with p9-Cdk1 or MEE for 1 h and analyzed as in (D). The results shown are representative of five independent experiments.

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: G2-state Cdc25C differs from original-state Cdc25C in basal activity and phosphoactivation (A) Schematic diagram of Xenopus Cdc25C interactions with binding partners. (B) Myc-Cdc25C immunoprecipitated from its TNT product (IP-Cdc25C) was mock-treated with EB or incubated with IOE or MEE for 1 h. The washed immunocomplexes were analyzed for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of partially purified phospho-Cdk1 (pCdk1) for the indicated times (right). In parallel, TNT-produced myc-Cdc25C 62DE was immunoprecipitated and analyzed. (C) IP-Cdc25C S287A was analyzed as described for IP-Cdc25C in (B). (D) IP-Cdc25C was mock-treated with EB or incubated with p9-Cdk1 or MEE for 1 h. Washed immunocomplexes were examined for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of endogenous Cdk1 in 1:10-diluted IOE⁎ supplemented with okadaic acid (IOE⁎/OA) for the indicated times (right). Similar results were obtained in four additional independent experiments with moderate variations in phosphorylation conditions. (E) IOE-Cdc25C (lower images) was mock-treated with EB or incubated with p9-Cdk1 or MEE for 1 h and analyzed as in (D). The results shown are representative of five independent experiments.

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Activity Assay, Binding Assay, Immunoprecipitation, Incubation, Western Blot, De-Phosphorylation Assay, Purification, Produced, Phospho-proteomics

    Site-specific and site-comprehensive phosphorylation regulate original-state Cdc25C activity differently (A) Myc-Cdc25C immunoprecipitated from its TNT product (IP-Cdc25C) was mock-treated with EB or incubated with individual TNT-produced kinases or MEE for 2 h. Washed immunocomplexes were analyzed for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of pCdk1 for the indicated times (right). The results shown are representative of two independent experiments. (B) IP-Cdc25C was mock-treated with EB or incubated with 1:4-diluted TNT kinase samples or 1:4-diluted MEE for 2 h, and immunocomplexes were analyzed as in (A). (C) IP-Cdc25C was mock-treated with EB or incubated with either a mixture of four TNT kinases (4K mix) or 1:4-diluted MEE for 2 h, and immunocomplexes were analyzed as in (A). (D) IP-Cdc25C was mock-treated with EB or incubated with MEE in the presence or absence of either the four specific kinase inhibitors (4KI) or the pan-kinase inhibitor staurosporine (ST) for 2 h. Washed immunocomplexes were analyzed as in (A).

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: Site-specific and site-comprehensive phosphorylation regulate original-state Cdc25C activity differently (A) Myc-Cdc25C immunoprecipitated from its TNT product (IP-Cdc25C) was mock-treated with EB or incubated with individual TNT-produced kinases or MEE for 2 h. Washed immunocomplexes were analyzed for Cdc25C mobility shifts by anti-Myc immunoblotting (left) and for Cdc25C activity by measuring dephosphorylation of pCdk1 for the indicated times (right). The results shown are representative of two independent experiments. (B) IP-Cdc25C was mock-treated with EB or incubated with 1:4-diluted TNT kinase samples or 1:4-diluted MEE for 2 h, and immunocomplexes were analyzed as in (A). (C) IP-Cdc25C was mock-treated with EB or incubated with either a mixture of four TNT kinases (4K mix) or 1:4-diluted MEE for 2 h, and immunocomplexes were analyzed as in (A). (D) IP-Cdc25C was mock-treated with EB or incubated with MEE in the presence or absence of either the four specific kinase inhibitors (4KI) or the pan-kinase inhibitor staurosporine (ST) for 2 h. Washed immunocomplexes were analyzed as in (A).

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Phospho-proteomics, Activity Assay, Immunoprecipitation, Incubation, Produced, Western Blot, De-Phosphorylation Assay

    Both G2-state conversion and mitotic phosphorylation inhibit the regulatory-catalytic domain interaction of Cdc25C (A) Schematic illustration of Cdc25C structure and summary of results from testing various myc-tagged Cdc25C proteins for interaction with GST-Cdc25C 375-550ˆ . (B) Myc-tagged Cdc25C 9-550 , Cdc25C 9-375 , and Cdc25C 375-550 were each adsorbed with GST or GST-Cdc25C 375-550ˆ beads for 90 min. Input proteins (1/20) and bead eluates were analyzed by anti-Myc immunoblotting after Ponceau S (Ponc S) staining. Relative pulldown values (R pulldown) were calculated by normalizing the pulldown signal to the corresponding input signal and expressed relative to the indicated control, which was set to 1. (C) Myc-tagged Cdc25C 9-375 (9–375), Cdc25C 9-129 (9–129), Cdc25C 126-213 (126–213), and Cdc25C 212-375 (212–375) were processed as in (B). The results shown are representative of three independent experiments. (D) Myc-Cdc25C 9-375 was mock-treated with EB or incubated with IOE, MEE, or the indicated TNT kinase samples for 2 h. Treated myc-Cdc25C 9-375 and untreated myc-Cdc25C 9-375 62DE were analyzed as in (B). Similar results were obtained in an additional experiment using undiluted MEE or individual TNT-produced kinases for phosphorylation.

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: Both G2-state conversion and mitotic phosphorylation inhibit the regulatory-catalytic domain interaction of Cdc25C (A) Schematic illustration of Cdc25C structure and summary of results from testing various myc-tagged Cdc25C proteins for interaction with GST-Cdc25C 375-550ˆ . (B) Myc-tagged Cdc25C 9-550 , Cdc25C 9-375 , and Cdc25C 375-550 were each adsorbed with GST or GST-Cdc25C 375-550ˆ beads for 90 min. Input proteins (1/20) and bead eluates were analyzed by anti-Myc immunoblotting after Ponceau S (Ponc S) staining. Relative pulldown values (R pulldown) were calculated by normalizing the pulldown signal to the corresponding input signal and expressed relative to the indicated control, which was set to 1. (C) Myc-tagged Cdc25C 9-375 (9–375), Cdc25C 9-129 (9–129), Cdc25C 126-213 (126–213), and Cdc25C 212-375 (212–375) were processed as in (B). The results shown are representative of three independent experiments. (D) Myc-Cdc25C 9-375 was mock-treated with EB or incubated with IOE, MEE, or the indicated TNT kinase samples for 2 h. Treated myc-Cdc25C 9-375 and untreated myc-Cdc25C 9-375 62DE were analyzed as in (B). Similar results were obtained in an additional experiment using undiluted MEE or individual TNT-produced kinases for phosphorylation.

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Phospho-proteomics, Western Blot, Staining, Control, Incubation, Produced, GST Pulldown Assay

    Cdc25C IDR interaction with cyclin B is inhibited by G2-state conversion and site-comprehensive phosphorylation (A) Schematic diagram of Cdc25C structure and summary of results from testing various Cdc25C proteins for interaction with GST-tagged Xenopus cyclin B2 (GST-CycB2). (B) Myc-tagged Cdc25C 9-550 (9–550), Cdc25C 9-375 (9–375), and Cdc25C 375-550 (375–550) were each adsorbed with GST or GST-CycB2 beads for 90 min. Input proteins (1/20) and bead eluates were analyzed by anti-Myc immunoblotting after Ponceau S (Ponc S) staining. Relative pulldown values (R pulldown) were calculated by normalizing the pulldown signal to the corresponding input signal. Values are expressed relative to the indicated control, which was set to 1. (C) Myc-tagged Cdc25C 9-375 (9–375), Cdc25C 9-129 (9–129), Cdc25C 126-213 (126–213), and Cdc25C 212-375 (212–375) were processed as in (B). The results shown are representative of three independent experiments. (D) Myc-tagged Cdc25C 9-550 (myc-Cdc25C) was mock-treated with EB or incubated with IOE, MEE, or the indicated TNT kinase samples for 2 h. Treated myc-Cdc25C and untreated myc-Cdc25C 62DE were analyzed as in (B).

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: Cdc25C IDR interaction with cyclin B is inhibited by G2-state conversion and site-comprehensive phosphorylation (A) Schematic diagram of Cdc25C structure and summary of results from testing various Cdc25C proteins for interaction with GST-tagged Xenopus cyclin B2 (GST-CycB2). (B) Myc-tagged Cdc25C 9-550 (9–550), Cdc25C 9-375 (9–375), and Cdc25C 375-550 (375–550) were each adsorbed with GST or GST-CycB2 beads for 90 min. Input proteins (1/20) and bead eluates were analyzed by anti-Myc immunoblotting after Ponceau S (Ponc S) staining. Relative pulldown values (R pulldown) were calculated by normalizing the pulldown signal to the corresponding input signal. Values are expressed relative to the indicated control, which was set to 1. (C) Myc-tagged Cdc25C 9-375 (9–375), Cdc25C 9-129 (9–129), Cdc25C 126-213 (126–213), and Cdc25C 212-375 (212–375) were processed as in (B). The results shown are representative of three independent experiments. (D) Myc-tagged Cdc25C 9-550 (myc-Cdc25C) was mock-treated with EB or incubated with IOE, MEE, or the indicated TNT kinase samples for 2 h. Treated myc-Cdc25C and untreated myc-Cdc25C 62DE were analyzed as in (B).

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Phospho-proteomics, Western Blot, Staining, Control, Incubation, GST Pulldown Assay

    Site-comprehensive phosphorylation disrupts IDR-mediated self-association of Cdc25C (A) TNT-produced soluble HA-Cdc25C 9-375 (HA-TNT input) was adsorbed with immunoprecipitated myc-Cdc25C 9-375 for 1 h. Following two bead washes with the indicated buffers, HA-TNT input (1/10) and bead eluates (Myc-IP pulldown) were analyzed by immunoblotting with anti-Myc and anti-HA antibodies. TX, 0.5% Triton X-100; NaCl, 500 mM NaCl. (B) Soluble HA-Cdc25C 9-375 and immunoprecipitated myc-Cdc25C 9-375 were each mock-treated with EB or incubated with IOE for 2 h, and equivalently treated pairs were then incubated together for 1 h. Following two washes of beads with EB, bead eluates (Myc-IP pulldown) were analyzed in parallel with HA-TNT input (1/20) by immunoblotting with anti-Myc and anti-HA antibodies. The results shown are representative of two independent experiments. (C) Soluble HA-Cdc25C 9-375 and immunoprecipitated myc-Cdc25C 9-375 were each mock-treated with EB or incubated with mitotic extract (ME) derived from synchronized HEK293T cells for 2 h, whereas soluble HA-Cdc25C 9-375 62DE and immunoprecipitated myc-Cdc25C 9-375 62DE were untreated. Equivalently treated pairs were then incubated together for 1 h, and samples were processed as in (B). The results shown are representative of two independent experiments. (D) TNT-produced soluble HA-Cdc25C 9-375 (HA-TNT input) was adsorbed with immunoprecipitated myc-Cdc25C 9-375 for 1.5 h, and pelleted beads were incubated with two volumes of EB, EB/ATP/MC (microcystin), or MEE for 2 or 4 min. Following two bead washes with EB, HA-TNT input (1/10) and bead eluates (Myc-IP pulldown) were analyzed by immunoblotting with anti-Myc and anti-HA antibodies.

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: Site-comprehensive phosphorylation disrupts IDR-mediated self-association of Cdc25C (A) TNT-produced soluble HA-Cdc25C 9-375 (HA-TNT input) was adsorbed with immunoprecipitated myc-Cdc25C 9-375 for 1 h. Following two bead washes with the indicated buffers, HA-TNT input (1/10) and bead eluates (Myc-IP pulldown) were analyzed by immunoblotting with anti-Myc and anti-HA antibodies. TX, 0.5% Triton X-100; NaCl, 500 mM NaCl. (B) Soluble HA-Cdc25C 9-375 and immunoprecipitated myc-Cdc25C 9-375 were each mock-treated with EB or incubated with IOE for 2 h, and equivalently treated pairs were then incubated together for 1 h. Following two washes of beads with EB, bead eluates (Myc-IP pulldown) were analyzed in parallel with HA-TNT input (1/20) by immunoblotting with anti-Myc and anti-HA antibodies. The results shown are representative of two independent experiments. (C) Soluble HA-Cdc25C 9-375 and immunoprecipitated myc-Cdc25C 9-375 were each mock-treated with EB or incubated with mitotic extract (ME) derived from synchronized HEK293T cells for 2 h, whereas soluble HA-Cdc25C 9-375 62DE and immunoprecipitated myc-Cdc25C 9-375 62DE were untreated. Equivalently treated pairs were then incubated together for 1 h, and samples were processed as in (B). The results shown are representative of two independent experiments. (D) TNT-produced soluble HA-Cdc25C 9-375 (HA-TNT input) was adsorbed with immunoprecipitated myc-Cdc25C 9-375 for 1.5 h, and pelleted beads were incubated with two volumes of EB, EB/ATP/MC (microcystin), or MEE for 2 or 4 min. Following two bead washes with EB, HA-TNT input (1/10) and bead eluates (Myc-IP pulldown) were analyzed by immunoblotting with anti-Myc and anti-HA antibodies.

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Phospho-proteomics, Produced, Immunoprecipitation, Western Blot, Incubation, Derivative Assay

    A unique role of site-comprehensive phosphorylation in dissociating G2-state Cdc25C from prebound partners (A) Wild-type (WT) or S287A mutant myc-Cdc25Cˆ was expressed in Xenopus oocytes by mRNA injection. Extracts of progesterone-matured (Prog+) or unstimulated (Prog-) oocytes were incubated with immobilized GST-14-3-3. Input oocyte extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting after Ponceau S (Ponc S) staining. (B) Xenopus oocytes ectopically expressing myc-Cdc25Cˆ were unstimulated (control), injected with a subthreshold level of mRNA encoding myc-CA-MEK1 (CA-MEK1), or matured with progesterone (Prog+). Oocyte extracts were analyzed as in (A). (C) WT and two supershift-defective mutant forms of myc-Cdc25Cˆ were assayed for binding to GST-14-3-3 as in (A). (D) WT and three double phosphodefective mutant forms of myc-Cdc25Cˆ were assayed for binding to GST-14-3-3 as in (A). (E) WT or T48V-T138V-S205A (T2S1) mutant form of myc-Cdc25Cˆ was expressed in Xenopus oocytes. Extracts of control or Prog+ oocytes were immunoprecipitated with anti-CRM1 antibodies or incubated with immobilized GST-14-3-3. Input oocyte extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also probed with anti-CRM1 antibodies or stained with Ponc S. (F) WT or T2S1 mutant form of myc-Cdc25Cˆ was expressed in Xenopus oocytes. Extracts of control or Prog+ oocytes were immunoprecipitated with anti-MAPK or anti-RSK1/2 antibodies. Input oocyte extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also immunoblotted with anti-MAPK or anti-RSK2 antibodies.

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: A unique role of site-comprehensive phosphorylation in dissociating G2-state Cdc25C from prebound partners (A) Wild-type (WT) or S287A mutant myc-Cdc25Cˆ was expressed in Xenopus oocytes by mRNA injection. Extracts of progesterone-matured (Prog+) or unstimulated (Prog-) oocytes were incubated with immobilized GST-14-3-3. Input oocyte extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting after Ponceau S (Ponc S) staining. (B) Xenopus oocytes ectopically expressing myc-Cdc25Cˆ were unstimulated (control), injected with a subthreshold level of mRNA encoding myc-CA-MEK1 (CA-MEK1), or matured with progesterone (Prog+). Oocyte extracts were analyzed as in (A). (C) WT and two supershift-defective mutant forms of myc-Cdc25Cˆ were assayed for binding to GST-14-3-3 as in (A). (D) WT and three double phosphodefective mutant forms of myc-Cdc25Cˆ were assayed for binding to GST-14-3-3 as in (A). (E) WT or T48V-T138V-S205A (T2S1) mutant form of myc-Cdc25Cˆ was expressed in Xenopus oocytes. Extracts of control or Prog+ oocytes were immunoprecipitated with anti-CRM1 antibodies or incubated with immobilized GST-14-3-3. Input oocyte extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also probed with anti-CRM1 antibodies or stained with Ponc S. (F) WT or T2S1 mutant form of myc-Cdc25Cˆ was expressed in Xenopus oocytes. Extracts of control or Prog+ oocytes were immunoprecipitated with anti-MAPK or anti-RSK1/2 antibodies. Input oocyte extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also immunoblotted with anti-MAPK or anti-RSK2 antibodies.

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Phospho-proteomics, Mutagenesis, Injection, Incubation, Western Blot, Staining, Expressing, Control, Binding Assay, Immunoprecipitation

    Opposing effects of two distinct types of mitotic phosphorylation on recruitment of new partners to G2-state Cdc25C (A) Oocytes ectopically expressing myc-Cdc25Cˆ were left unstimulated (control), matured with progesterone (Prog+), or injected with a subthreshold level of CA-MEK1 mRNA, and oocyte extracts were incubated with immobilized GST-ΔCycB. Input extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also stained with Ponceau S (Ponc S). (B) Myc-Cdc25C immunoprecipitated from HEK293T cell lysates was treated with IOE for 2 h (IOE-Cdc25C) and then mock-treated with EB or incubated with the indicated TNT kinase samples for 2 h. Washed immunocomplexes were incubated with soluble GST-ΔCycB for 1 h, and bead eluates were analyzed by immunoblotting with anti-Myc and anti-GST antibodies. (C) WT or T2S1 mutant myc-Cdc25Cˆ was expressed in Xenopus oocytes by mRNA injection, immunoprecipitated with anti-Myc antibodies, and incubated with activated recombinant MAPK in the presence of 1 mM ATP or 10 mM EDTA, which inhibits phosphorylation by chelating magnesium. Washed immunocomplexes were processed as in (B). (D) WT or T2S1 mutant myc-Cdc25Cˆ was expressed in oocytes and analyzed as in (A). (E) WT or T48V mutant myc-Cdc25C 9-213 was expressed in oocytes with or without co-expression of subthreshold CA-MEK1, and extracts were immunoprecipitated with anti-CRM1 antibodies. Input extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also immunoblotted with anti-CRM1 antibodies. (F) IOE-Cdc25C was incubated with the indicated TNT kinase samples for 2 h and then processed as in (B). (G) WT or T2S1 mutant myc-Cdc25Cˆ was co-expressed in oocytes with HA-Plx1ˆ by mRNA injection, and extracts from control or Prog+ oocytes were immunoprecipitated with anti-HA antibodies. Input extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also probed with anti-HA antibodies. The results shown are representative of two independent experiments. (H) IOE-Cdc25C was mock-treated with EB or incubated with 1:4-diluted MEE or 4K mix for 2 h, and washed immunocomplexes were incubated with soluble GST-ΔCycB and GST-p9 for 1 h. Bead eluates were analyzed by immunoblotting with anti-Myc and anti-GST antibodies.

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet: Opposing effects of two distinct types of mitotic phosphorylation on recruitment of new partners to G2-state Cdc25C (A) Oocytes ectopically expressing myc-Cdc25Cˆ were left unstimulated (control), matured with progesterone (Prog+), or injected with a subthreshold level of CA-MEK1 mRNA, and oocyte extracts were incubated with immobilized GST-ΔCycB. Input extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also stained with Ponceau S (Ponc S). (B) Myc-Cdc25C immunoprecipitated from HEK293T cell lysates was treated with IOE for 2 h (IOE-Cdc25C) and then mock-treated with EB or incubated with the indicated TNT kinase samples for 2 h. Washed immunocomplexes were incubated with soluble GST-ΔCycB for 1 h, and bead eluates were analyzed by immunoblotting with anti-Myc and anti-GST antibodies. (C) WT or T2S1 mutant myc-Cdc25Cˆ was expressed in Xenopus oocytes by mRNA injection, immunoprecipitated with anti-Myc antibodies, and incubated with activated recombinant MAPK in the presence of 1 mM ATP or 10 mM EDTA, which inhibits phosphorylation by chelating magnesium. Washed immunocomplexes were processed as in (B). (D) WT or T2S1 mutant myc-Cdc25Cˆ was expressed in oocytes and analyzed as in (A). (E) WT or T48V mutant myc-Cdc25C 9-213 was expressed in oocytes with or without co-expression of subthreshold CA-MEK1, and extracts were immunoprecipitated with anti-CRM1 antibodies. Input extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also immunoblotted with anti-CRM1 antibodies. (F) IOE-Cdc25C was incubated with the indicated TNT kinase samples for 2 h and then processed as in (B). (G) WT or T2S1 mutant myc-Cdc25Cˆ was co-expressed in oocytes with HA-Plx1ˆ by mRNA injection, and extracts from control or Prog+ oocytes were immunoprecipitated with anti-HA antibodies. Input extracts (1/10) and bead eluates were analyzed by anti-Myc immunoblotting, and bead eluates were also probed with anti-HA antibodies. The results shown are representative of two independent experiments. (H) IOE-Cdc25C was mock-treated with EB or incubated with 1:4-diluted MEE or 4K mix for 2 h, and washed immunocomplexes were incubated with soluble GST-ΔCycB and GST-p9 for 1 h. Bead eluates were analyzed by immunoblotting with anti-Myc and anti-GST antibodies.

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques: Phospho-proteomics, Expressing, Control, Injection, Incubation, Western Blot, Staining, Immunoprecipitation, Mutagenesis, Recombinant

    Journal: iScience

    Article Title: Site-comprehensive phosphorylation dismantles a disordered interaction hub to drive Cdc25C activation

    doi: 10.1016/j.isci.2026.118169

    Figure Lengend Snippet:

    Article Snippet: Anti-Myc for IB or IP , OriGene , Cat# TA150121; RRID: AB_2622266.

    Techniques:

    Overexpression of Trx1 mitigates TDP-43 pathology in N2a cells. (A,B) Overexpressing Trx1 significantly reduces cytoplasmic TDP-43 aggregation in N2a cells. 48 h post-transfection as indicated, N2a cells were stained with anti -TDP-43 (A). Yellow arrows indicate cytoplasmic TDP-43 inclusions. Cytoplasmic TDP-43 inclusions were normalized to the corresponding cell number and presented as a percentage of cells with cytoplasmic TDP-43 inclusions (B) (n = 3, one-way ANOVA, post-hoc Tukey's test). (C-F) Overexpressing Trx1 significantly reduces cleaved caspase 3 in N2a cells. 48 h post-transfection, c-Cas3 was assessed by immunostaining with c-Cas3-specific antibody (C) and Western blot analysis with pro-caspase-3 antibody (E). The percentages of c-Cas3-positive cells were quantified from immunostaining images (D), and c-Cas3 protein levels were quantified by Western blotting and normalized to the GAPDH level and presented relative to the mean value of the control group (F). (D: n = 4, one-way ANOVA, post-hoc Tukey's test, F: n = 3, unpaired t- test). Nuclei were stained with DAPI (blue). All scale bars correspond to 25 μm. All values are means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Redox Biology

    Article Title: Cytoplasmic TDP-43 aggregation promotes oxidative stress and neurotoxicity through Trx1 mRNA sequestration and translational suppression

    doi: 10.1016/j.redox.2026.104469

    Figure Lengend Snippet: Overexpression of Trx1 mitigates TDP-43 pathology in N2a cells. (A,B) Overexpressing Trx1 significantly reduces cytoplasmic TDP-43 aggregation in N2a cells. 48 h post-transfection as indicated, N2a cells were stained with anti -TDP-43 (A). Yellow arrows indicate cytoplasmic TDP-43 inclusions. Cytoplasmic TDP-43 inclusions were normalized to the corresponding cell number and presented as a percentage of cells with cytoplasmic TDP-43 inclusions (B) (n = 3, one-way ANOVA, post-hoc Tukey's test). (C-F) Overexpressing Trx1 significantly reduces cleaved caspase 3 in N2a cells. 48 h post-transfection, c-Cas3 was assessed by immunostaining with c-Cas3-specific antibody (C) and Western blot analysis with pro-caspase-3 antibody (E). The percentages of c-Cas3-positive cells were quantified from immunostaining images (D), and c-Cas3 protein levels were quantified by Western blotting and normalized to the GAPDH level and presented relative to the mean value of the control group (F). (D: n = 4, one-way ANOVA, post-hoc Tukey's test, F: n = 3, unpaired t- test). Nuclei were stained with DAPI (blue). All scale bars correspond to 25 μm. All values are means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The coding sequences of full-length human wild-type thioredoxin 1 ( hTrx1 ; NM_003329 ) with a C-terminal Myc-FLAG tag was amplified from pCMV6-hTrx1-Myc-FLAG (OriGene, RC208876) and cloned into the pAAV-MCS expression vector using the Bam HI and Xba I restriction sites.

    Techniques: Over Expression, Pathology, Transfection, Staining, Immunostaining, Western Blot, Analysis, Control

    Cytoplasmic TDP-43 sequesters Trx1 mRNAs into insoluble TDP-43 inclusions, resulting in its translational suppression. (A-C) TDP-43 protein binds to Trx1 mRNA. For TDP-43 RIP, hTDP-43-FLAG proteins were immunoprecipitated using anti-FLAG antibody (A). N2a cells expressing ectopic hTDP-43-5FL mutant served as a negative control. Endogenous Tdp-43 (B) and Trx1 mRNAs (C) bound to TDP-43 proteins were analyzed by qRT-PCR. Each level was presented as a relative fold change compared to the control (n = 3, one-way ANOVA, post-hoc Tukey's test). (D,E) Overexpression of hTDP-43 induced autoregulation, resulting in reduced expression of endogenous mouse TDP-43.48 h post-transfection, TDP-43 was assessed by Western blot analysis with TDP-43-specific antibody which detects both human- and mouse TDP-43 (D). Endogenous mouse TDP-43 level was normalized by the corresponding GAPDH level and presented relative to the mean value of the control group (E) (n = 3, unpaired t- test). N2a cells expressing FLAG tag served as a negative control. (F,G) The RNA recognition motifs (RRMs) of TDP-43 are required for TDP-43-mediated regulation of Trx1 expression. 48 h post-transfection as indicated, Trx1 protein levels were analyzed by Western blot (F). Trx1 protein level was normalized to the corresponding GAPDH level and presented relative to the mean value of the control group (G) (n = 3, one-way ANOVA, post-hoc Tukey's test). (H,I) The insoluble-to-soluble ratio of Trx1 mRNAs is significantly increased upon TDP-43 overexpression in N2a cells. 48 h post-transfection, cell lysates were first fractionated into nuclear and cytoplasmic fractions. The resulting cytoplasmic fractions were further fractioned into Triton X-100–soluble and –insoluble fractions as described in the Materials and Methods (H). The insoluble-to-soluble ratio of Trx1 mRNAs is presented as a relative fold change to control (I) (n = 3, unpaired t- test). (J,K) The levels of Trx1 mRNAs bound to ribosomes are significantly decreased upon TDP-43 overexpression in N2a cells. N2a cells were transiently transfected with FLAG-tagged RPL22 for ribosome isolation. 48 h post-transfection as indicated, ribosomes were immunoprecipitated using anti-FLAG antibody (J). N2a cells without hTDP-43 expression served as a control. The levels of Trx1 mRNAs bound to ribosomes were measured by qRT-PCR and normalized by the corresponding levels of immunoprecipitated RPL22 protein. Each level was presented as a relative fold change to control (K) (n = 3, unpaired t -test). All values are means ± SEM. n.s. = non-significant, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Redox Biology

    Article Title: Cytoplasmic TDP-43 aggregation promotes oxidative stress and neurotoxicity through Trx1 mRNA sequestration and translational suppression

    doi: 10.1016/j.redox.2026.104469

    Figure Lengend Snippet: Cytoplasmic TDP-43 sequesters Trx1 mRNAs into insoluble TDP-43 inclusions, resulting in its translational suppression. (A-C) TDP-43 protein binds to Trx1 mRNA. For TDP-43 RIP, hTDP-43-FLAG proteins were immunoprecipitated using anti-FLAG antibody (A). N2a cells expressing ectopic hTDP-43-5FL mutant served as a negative control. Endogenous Tdp-43 (B) and Trx1 mRNAs (C) bound to TDP-43 proteins were analyzed by qRT-PCR. Each level was presented as a relative fold change compared to the control (n = 3, one-way ANOVA, post-hoc Tukey's test). (D,E) Overexpression of hTDP-43 induced autoregulation, resulting in reduced expression of endogenous mouse TDP-43.48 h post-transfection, TDP-43 was assessed by Western blot analysis with TDP-43-specific antibody which detects both human- and mouse TDP-43 (D). Endogenous mouse TDP-43 level was normalized by the corresponding GAPDH level and presented relative to the mean value of the control group (E) (n = 3, unpaired t- test). N2a cells expressing FLAG tag served as a negative control. (F,G) The RNA recognition motifs (RRMs) of TDP-43 are required for TDP-43-mediated regulation of Trx1 expression. 48 h post-transfection as indicated, Trx1 protein levels were analyzed by Western blot (F). Trx1 protein level was normalized to the corresponding GAPDH level and presented relative to the mean value of the control group (G) (n = 3, one-way ANOVA, post-hoc Tukey's test). (H,I) The insoluble-to-soluble ratio of Trx1 mRNAs is significantly increased upon TDP-43 overexpression in N2a cells. 48 h post-transfection, cell lysates were first fractionated into nuclear and cytoplasmic fractions. The resulting cytoplasmic fractions were further fractioned into Triton X-100–soluble and –insoluble fractions as described in the Materials and Methods (H). The insoluble-to-soluble ratio of Trx1 mRNAs is presented as a relative fold change to control (I) (n = 3, unpaired t- test). (J,K) The levels of Trx1 mRNAs bound to ribosomes are significantly decreased upon TDP-43 overexpression in N2a cells. N2a cells were transiently transfected with FLAG-tagged RPL22 for ribosome isolation. 48 h post-transfection as indicated, ribosomes were immunoprecipitated using anti-FLAG antibody (J). N2a cells without hTDP-43 expression served as a control. The levels of Trx1 mRNAs bound to ribosomes were measured by qRT-PCR and normalized by the corresponding levels of immunoprecipitated RPL22 protein. Each level was presented as a relative fold change to control (K) (n = 3, unpaired t -test). All values are means ± SEM. n.s. = non-significant, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The coding sequences of full-length human wild-type thioredoxin 1 ( hTrx1 ; NM_003329 ) with a C-terminal Myc-FLAG tag was amplified from pCMV6-hTrx1-Myc-FLAG (OriGene, RC208876) and cloned into the pAAV-MCS expression vector using the Bam HI and Xba I restriction sites.

    Techniques: Immunoprecipitation, Expressing, Mutagenesis, Negative Control, Quantitative RT-PCR, Control, Over Expression, Transfection, Western Blot, Analysis, FLAG-tag, Isolation

    Trx1 regulates oxidative stress and mitochondrial bioenergetics in a N2a model of TDP-43 overexpression. (A,B) Inhibiting Trx1 significantly enhances ROS levels in N2a-hTDP-43 cells. 48 h post-transfection as indicated, N2a cells were stained with CellROX Deep Red dye for ROS (A). Nuclei were stained with DAPI (blue). Scale bars correspond to 25 μm. Each level was normalized to the corresponding cell number and presented as a relative fold change to control (B) (n = 4, one-way ANOVA, post-hoc Tukey's test). (C,D) Overexpressing Trx1 significantly reduces ROS levels in N2a-hTDP-43 cells. Each level was normalized to the corresponding cell number and presented as a relative fold change compared to control (D) (n = 3, one-way ANOVA, post-hoc Tukey's test). (E-H) Inhibiting Trx1 exacerbates mitochondrial dysfunction in N2a-hTDP-43 cells. The basal respiration (F), ATP production (G), and maximum respiratory capacity (H) were measured as described in the Materials and Methods (n = 6 - 7, one-way ANOVA, post-hoc Tukey's test). (I-L) Overexpressing Trx1 attenuates mitochondrial dysfunction in N2a-hTDP-43 cells (n = 6 ∼ 7, one-way ANOVA, post-hoc Tukey's test). All values are means ± SEM. n.s. = non-significant, * p < 0.05, ** p < 0.01.

    Journal: Redox Biology

    Article Title: Cytoplasmic TDP-43 aggregation promotes oxidative stress and neurotoxicity through Trx1 mRNA sequestration and translational suppression

    doi: 10.1016/j.redox.2026.104469

    Figure Lengend Snippet: Trx1 regulates oxidative stress and mitochondrial bioenergetics in a N2a model of TDP-43 overexpression. (A,B) Inhibiting Trx1 significantly enhances ROS levels in N2a-hTDP-43 cells. 48 h post-transfection as indicated, N2a cells were stained with CellROX Deep Red dye for ROS (A). Nuclei were stained with DAPI (blue). Scale bars correspond to 25 μm. Each level was normalized to the corresponding cell number and presented as a relative fold change to control (B) (n = 4, one-way ANOVA, post-hoc Tukey's test). (C,D) Overexpressing Trx1 significantly reduces ROS levels in N2a-hTDP-43 cells. Each level was normalized to the corresponding cell number and presented as a relative fold change compared to control (D) (n = 3, one-way ANOVA, post-hoc Tukey's test). (E-H) Inhibiting Trx1 exacerbates mitochondrial dysfunction in N2a-hTDP-43 cells. The basal respiration (F), ATP production (G), and maximum respiratory capacity (H) were measured as described in the Materials and Methods (n = 6 - 7, one-way ANOVA, post-hoc Tukey's test). (I-L) Overexpressing Trx1 attenuates mitochondrial dysfunction in N2a-hTDP-43 cells (n = 6 ∼ 7, one-way ANOVA, post-hoc Tukey's test). All values are means ± SEM. n.s. = non-significant, * p < 0.05, ** p < 0.01.

    Article Snippet: The coding sequences of full-length human wild-type thioredoxin 1 ( hTrx1 ; NM_003329 ) with a C-terminal Myc-FLAG tag was amplified from pCMV6-hTrx1-Myc-FLAG (OriGene, RC208876) and cloned into the pAAV-MCS expression vector using the Bam HI and Xba I restriction sites.

    Techniques: Over Expression, Transfection, Staining, Control

    a, RADAR mechanism. RADAR consists of three parts: an optional marker (red), a sensor sequence (orange) complementary to the target RNA except an A:C mismatch at the UAG stop codon, and a cargo (green). In the absence of target RNA, the cargo is not expressed due to the stop codon in the sensor. When sensor is bound to its target, the double-strand RNA formed between sensor and target will induce ADAR-mediated A-to-I editing, thus removing the stop codon and enabling cargo expression. b, ORCA overview. c, RT-qPCR C q values of four gene targets in four cell lines. Each dot represents one technical replicate. d , Schematic showing targeting regions of identified sensors for each transcript. Colored box: coding sequence. Black line: 5’ or 3’ UTR. Red line: sensor target. Drawn to scale (MYC-s1 = 180 nt). e,f , GFP intensity of indicated cells transfected with the RADAR reporter (top) plus ADAR1p150 plasmids. Scramble sensor: a control for background payload expression. g-i , Representative fluorescent images of cells transfected with RADAR (shown in e and f ) and ADAR1p150 plasmids. SNU16 and HuG1N are suspension cells. Images taken at one Z-section. Scale bar = 275 μm. j-l , GFP intensity of COLO320DM ( j ), SNU16 ( k ), and HuG1N ( l ) cells co-transfected with RADAR (shown in e and f ), ADAR1p150 plasmids and siRNA. Ctrl: non-targeting siRNA. Each dot represents one biological replicate in e , f , j , k , l . Error bar represents standard deviation in all figures. Significance determined by two-tailed Student’s t -test. *: p<0.05, **: p<0.01, ***: p<0.001, ****: p<0.0001.

    Journal: bioRxiv

    Article Title: Targeted cancer ablation via programmable sensing of amplified oncogenic RNA

    doi: 10.64898/2026.11.02.763782

    Figure Lengend Snippet: a, RADAR mechanism. RADAR consists of three parts: an optional marker (red), a sensor sequence (orange) complementary to the target RNA except an A:C mismatch at the UAG stop codon, and a cargo (green). In the absence of target RNA, the cargo is not expressed due to the stop codon in the sensor. When sensor is bound to its target, the double-strand RNA formed between sensor and target will induce ADAR-mediated A-to-I editing, thus removing the stop codon and enabling cargo expression. b, ORCA overview. c, RT-qPCR C q values of four gene targets in four cell lines. Each dot represents one technical replicate. d , Schematic showing targeting regions of identified sensors for each transcript. Colored box: coding sequence. Black line: 5’ or 3’ UTR. Red line: sensor target. Drawn to scale (MYC-s1 = 180 nt). e,f , GFP intensity of indicated cells transfected with the RADAR reporter (top) plus ADAR1p150 plasmids. Scramble sensor: a control for background payload expression. g-i , Representative fluorescent images of cells transfected with RADAR (shown in e and f ) and ADAR1p150 plasmids. SNU16 and HuG1N are suspension cells. Images taken at one Z-section. Scale bar = 275 μm. j-l , GFP intensity of COLO320DM ( j ), SNU16 ( k ), and HuG1N ( l ) cells co-transfected with RADAR (shown in e and f ), ADAR1p150 plasmids and siRNA. Ctrl: non-targeting siRNA. Each dot represents one biological replicate in e , f , j , k , l . Error bar represents standard deviation in all figures. Significance determined by two-tailed Student’s t -test. *: p<0.05, **: p<0.01, ***: p<0.001, ****: p<0.0001.

    Article Snippet: siRNAs targeting c-MYC , FGFR2 , KRAS , CDX2 , and the non-targeting control siRNA were purchased from Santa Cruz Biotechnology (catalog numbers: sc-29226, sc-29218, sc-35731, sc-43680, and sc-37007, respectively).

    Techniques: Marker, Sequencing, Expressing, Quantitative RT-PCR, Transfection, Control, Suspension, Standard Deviation, Two Tailed Test